BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 23217531)

  • 1. Atypical antipsychotic use and parkinsonism in dementia: effects of drug, dose, and sex.
    Marras C; Herrmann N; Anderson GM; Fischer HD; Wang X; Rochon PA
    Am J Geriatr Pharmacother; 2012 Dec; 10(6):381-9. PubMed ID: 23217531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia.
    Layton D; Harris S; Wilton LV; Shakir SA
    J Psychopharmacol; 2005 Sep; 19(5):473-82. PubMed ID: 16166184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are all commonly prescribed antipsychotics associated with greater mortality in elderly male veterans with dementia?
    Rossom RC; Rector TS; Lederle FA; Dysken MW
    J Am Geriatr Soc; 2010 Jun; 58(6):1027-34. PubMed ID: 20487081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of falls and fractures in older adults using atypical antipsychotic agents: a propensity score-adjusted, retrospective cohort study.
    Chatterjee S; Chen H; Johnson ML; Aparasu RR
    Am J Geriatr Pharmacother; 2012 Apr; 10(2):83-94. PubMed ID: 22306198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm.
    Maust DT; Kim HM; Seyfried LS; Chiang C; Kavanagh J; Schneider LS; Kales HC
    JAMA Psychiatry; 2015 May; 72(5):438-45. PubMed ID: 25786075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative risk of Parkinsonism associated with olanzapine, risperidone and quetiapine in older adults-a propensity score matched cohort study.
    Chyou TY; Nishtala R; Nishtala PS
    Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):692-700. PubMed ID: 32301237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.
    Finkel S; Kozma C; Long S; Greenspan A; Mahmoud R; Baser O; Engelhart L
    Int Psychogeriatr; 2005 Dec; 17(4):617-29. PubMed ID: 16202186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotics and mortality in Parkinsonism.
    Marras C; Gruneir A; Wang X; Fischer H; Gill SS; Herrmann N; Anderson GM; Hyson C; Rochon PA
    Am J Geriatr Psychiatry; 2012 Feb; 20(2):149-58. PubMed ID: 22273735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone?--A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting.
    Suzuki T; Uchida H; Watanabe K; Nomura K; Takeuchi H; Tomita M; Tsunoda K; Nio S; Den R; Manki H; Tanabe A; Yagi G; Kashima H
    Psychopharmacology (Berl); 2007 Dec; 195(2):285-95. PubMed ID: 17701027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in mortality rate in patients with dementia treated with atypical antipsychotics: a cohort study in outpatients in Central Italy.
    Piersanti M; Capannolo M; Turchetti M; Serroni N; De Berardis D; Evangelista P; Costantini P; Orsini A; Rossi A; Maggio R
    Riv Psichiatr; 2014; 49(1):34-40. PubMed ID: 24572582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Movement disorders in elderly users of risperidone and first generation antipsychotic agents: a Canadian population-based study.
    Vasilyeva I; Biscontri RG; Enns MW; Metge CJ; Alessi-Severini S
    PLoS One; 2013; 8(5):e64217. PubMed ID: 23696870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotics for delirium.
    Lonergan E; Britton AM; Luxenberg J; Wyller T
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005594. PubMed ID: 17443602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
    Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I;
    J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of discontinuation of atypical antipsychotics in the province of Québec: A retrospective prescription claims database analysis.
    Moisan J; Grégoire JP
    Clin Ther; 2010; 32 Suppl 1():S21-31. PubMed ID: 20152549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative risk of cerebrovascular adverse events in community-dwelling older adults using risperidone, olanzapine and quetiapine: a multiple propensity score-adjusted retrospective cohort study.
    Chatterjee S; Chen H; Johnson ML; Aparasu RR
    Drugs Aging; 2012 Oct; 29(10):807-17. PubMed ID: 23018582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes risk associated with use of olanzapine, quetiapine, and risperidone in veterans health administration patients with schizophrenia.
    Lambert BL; Cunningham FE; Miller DR; Dalack GW; Hur K
    Am J Epidemiol; 2006 Oct; 164(7):672-81. PubMed ID: 16943266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.
    Schneider LS; Tariot PN; Dagerman KS; Davis SM; Hsiao JK; Ismail MS; Lebowitz BD; Lyketsos CG; Ryan JM; Stroup TS; Sultzer DL; Weintraub D; Lieberman JA;
    N Engl J Med; 2006 Oct; 355(15):1525-38. PubMed ID: 17035647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical antipsychotics olanzapine, quetiapine, and risperidone and risk of acute major cardiovascular events in young and middle-aged adults: a nationwide register-based cohort study in Denmark.
    Pasternak B; Svanström H; Ranthe MF; Melbye M; Hviid A
    CNS Drugs; 2014 Oct; 28(10):963-73. PubMed ID: 24895158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.
    Dossenbach M; Pecenak J; Szulc A; Irimia V; Anders M; Logozar-Perkovic D; Peciukaitiene D; Kotler M; Smulevich AB; West TM; Lowry AJ; Treuer T
    J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profile of atypical-antipsychotics use in patients affected by dementia in the University Hospital of Ferrara.
    Chiabrando G; Bianchi S; Poluzzi E; Montanaro N; Scanavacca P
    Eur J Clin Pharmacol; 2010 Jul; 66(7):661-9. PubMed ID: 20464383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.